National HealthCare (NHC) Competitors $123.78 -0.80 (-0.64%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends NHC vs. HIMS, SHC, GH, OPCH, BTSG, VCYT, SGRY, LFST, PACS, and CONShould you be buying National HealthCare stock or one of its competitors? The main competitors of National HealthCare include Hims & Hers Health (HIMS), Sotera Health (SHC), Guardant Health (GH), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), PACS Group (PACS), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. National HealthCare vs. Hims & Hers Health Sotera Health Guardant Health Option Care Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group PACS Group Concentra Group Holdings Parent Hims & Hers Health (NYSE:HIMS) and National HealthCare (NYSE:NHC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Does the MarketBeat Community prefer HIMS or NHC? Hims & Hers Health received 35 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 37.37% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes3737.37% Underperform Votes6262.63% National HealthCareOutperform Votes2100.00% Underperform VotesNo Votes Does the media refer more to HIMS or NHC? In the previous week, Hims & Hers Health had 27 more articles in the media than National HealthCare. MarketBeat recorded 30 mentions for Hims & Hers Health and 3 mentions for National HealthCare. National HealthCare's average media sentiment score of 0.63 beat Hims & Hers Health's score of 0.26 indicating that National HealthCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 8 Very Positive mention(s) 6 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral National HealthCare 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, HIMS or NHC? National HealthCare has lower revenue, but higher earnings than Hims & Hers Health. National HealthCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.24B3.83-$23.55M$0.4449.55National HealthCare$1.23B1.55$66.80M$7.9815.51 Do analysts prefer HIMS or NHC? Hims & Hers Health currently has a consensus target price of $20.71, suggesting a potential downside of 4.98%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Hims & Hers Health is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of HIMS or NHC? 63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 56.4% of National HealthCare shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 13.8% of National HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, HIMS or NHC? Hims & Hers Health has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Is HIMS or NHC more profitable? National HealthCare has a net margin of 10.03% compared to Hims & Hers Health's net margin of 8.19%. Hims & Hers Health's return on equity of 10.97% beat National HealthCare's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% National HealthCare 10.03%6.87%4.68% SummaryHims & Hers Health beats National HealthCare on 13 of the 18 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get National HealthCare News Delivered to You Automatically Sign up to receive the latest news and ratings for NHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NHC vs. The Competition Export to ExcelMetricNational HealthCareSkilled nursing care facilities IndustryMedical SectorNYSE ExchangeMarket Cap$1.91B$2.58B$5.06B$19.87BDividend Yield1.94%1.06%5.18%3.53%P/E Ratio15.5115.71126.3242.94Price / Sales1.551.141,179.2518.99Price / Cash20.4815.7233.8617.86Price / Book2.083.784.685.52Net Income$66.80M$98.56M$119.54M$986.45M7 Day Performance-2.65%-2.39%-1.83%0.45%1 Month Performance3.46%-14.08%-3.60%1.05%1 Year PerformanceN/A17.00%31.91%24.67% National HealthCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NHCNational HealthCareN/A$123.79-0.6%N/AN/A$1.92B$1.14B15.5113,123HIMSHims & Hers Health3.5685 of 5 stars$21.80-7.4%$20.71-5.0%+181.8%$5.14B$872M49.551,046Analyst ForecastInsider TradeSHCSotera Health3.662 of 5 stars$13.21-2.9%$16.50+24.9%-5.2%$3.85B$1.05B52.843,000High Trading VolumeGHGuardant Health4.2853 of 5 stars$30.68flat$40.60+32.3%+28.4%$3.79B$563.95M0.001,779OPCHOption Care Health4.9784 of 5 stars$21.88+0.3%$30.83+40.9%-26.3%$3.71B$4.30B18.397,802Positive NewsBTSGBrightSpring Health Services2.9593 of 5 stars$18.79+0.8%$16.79-10.6%N/A$3.27B$10.59B-72.2735,000Positive NewsVCYTVeracyte4.1264 of 5 stars$39.20+0.1%$41.25+5.2%+50.5%$3.03B$361.05M-261.33790Analyst ForecastSGRYSurgery Partners3.0975 of 5 stars$22.51-1.1%$38.71+72.0%-29.9%$2.89B$2.74B-46.9013,500Analyst ForecastLFSTLifeStance Health Group1.7828 of 5 stars$7.22-0.3%$8.50+17.7%+16.5%$2.77B$1.06B0.009,325PACSPACS Group4.0685 of 5 stars$17.25+0.9%$39.88+131.2%N/A$2.61B$3.11B0.0032,433Analyst ForecastCONConcentra Group Holdings ParentN/A$21.27+4.9%$28.50+34.0%N/A$2.58B$1.84B0.0011,000Gap UpHigh Trading Volume Related Companies and Tools Related Companies HIMS Competitors SHC Competitors GH Competitors OPCH Competitors BTSG Competitors VCYT Competitors SGRY Competitors LFST Competitors PACS Competitors CON Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NHC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National HealthCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National HealthCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
